SCHEMBL20809990

SCHEMBL20809990

O=C(OCc1cc(-c2ccc(Cl)cc2Cl)no1)c1cccnc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.52
▸ KDM4E B2RXH2 2/20 0.52
▸ TDP1 Q9NUW8 4/20 0.51
▸ MAPK1 P28482 1/20 0.51
▸ KMT2A Q03164 5/20 0.50
▸ LMNA P02545 5/20 0.50
▸ MAPT P10636 3/20 0.50
▸ POLB P06746 2/20 0.50
▸ MEN1 O00255 3/20 0.48
▸ USP2 O75604 1/20 0.48
▸ L3MBTL1 Q9Y468 2/20 0.46
▸ RAB9A P51151 6/20 0.46
▸ HPGD P15428 3/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ CYP2D6 P10635 1/20 0.46
▸ CYP2C9 P11712 1/20 0.46
▸ AGTR1 P30556 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ NPC1 O15118 4/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20809994 0.89 ALDH1A1 (0.57) ALDH1A1KDM4ETDP1MAPK1KMT2A
SCHEMBL20810155 0.86 KMT2A (0.54) ALDH1A1KDM4ETDP1MAPK1KMT2A
SCHEMBL20810034 0.81 TSHR (0.55) ALDH1A1KMT2ALMNAMAPTPOLB
SCHEMBL20810014 0.81 KMT2A (0.62) ALDH1A1TDP1MAPK1KMT2ALMNA
SCHEMBL20810151 0.81 TDP1 (0.53) ALDH1A1KDM4ETDP1MAPK1KMT2A
SCHEMBL20810037 0.80 TDP1 (0.59) ALDH1A1KDM4ETDP1MAPK1KMT2A
SCHEMBL20810066 0.80 NPC1 (0.40) ALDH1A1TDP1MAPTPOLBL3MBTL1
SCHEMBL20810165 0.79 TDP1 (0.51) ALDH1A1KDM4ETDP1MAPK1KMT2A
SCHEMBL20810052 0.79 L3MBTL1 (0.45) ALDH1A1KDM4ETDP1KMT2AMAPT
SCHEMBL20810150 0.78 TDP1 (0.50) ALDH1A1KDM4ETDP1MAPK1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190077777-A1 NICOTINIC ACID DERIVATIVES, THEIR PREPARATION AND THE USE THEREOF XIAMEN INSTITUTE OF RARE EARTH MATERIALS (CN) 2019-03-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190077777-A1 NICOTINIC ACID DERIVATIVES, THEIR PREPARATION AND THE USE THEREOF H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, HCAR3, NAPRT ALDH1A1 1755/4885KDM4E 4802/4885TDP1 4152/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback